Pegvisomant in acromegaly: a multicenter real-life study in Argentina

Volume: 63, Issue: 4, Pages: 320 - 327
Published: Aug 22, 2019
Abstract
Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, hormonal and radiological data of acromegalic patients treated with PEGV in 17 Argentine centers. Results Seventy-five patients (age range 22-77, 51 females) with acromegaly have been treated with PEGV for up to...
Paper Details
Title
Pegvisomant in acromegaly: a multicenter real-life study in Argentina
Published Date
Aug 22, 2019
Volume
63
Issue
4
Pages
320 - 327
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.